Treating Pain in Sickle Cell Disease with Opioids: Clinical Advances,Ethical Pitfalls

Hassell K. L. , “Population Estimates of Sickle Cell Disease in the U.S.,” American Journal of Preventative Medicine 38, no. 4, Supp. (2010): S512–S521.

Sickle-Cell Anaemia: Report by the Secretariat, World Health Organization Fifty-Ninth World Health Assembly a59/9, Provisional Agenda Item 11.4 (April 24, 2006). <https://apps.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf>(last visited May 22, 2013).

Steinberg M. H. , “Management of Sickle Cell Disease,” New England Journal of Medicine 340 (1999): 1021–1030.

Dampier C. Ely B. Brodecki D. O'Neal P. , “Characteristics of Pain Managed at Home in Children and Adolescents with Sickle Cell Disease by Using Diary Self-Reports,” Journal of Pain 3, no. 6 (2002): 461–470;.

Brousseau D. C. Owens P. L. Mosso A. L. Panepinto J. A. Steiner C. A. , “Acute Care Utilization and Rehospitalizations for Sickle Cell Disease,” JAMA 303, no. 13 (2010): 1288–1294.

McClish D. K. Levenson J. L. Penberthy L. T. Roseff S. D. Bovbjerg V. E. Roberts J. D. Aisiku I. P. Smith W. R. , “Gender Differences in Pain and Health Care Utilization for Adult Sickle Cell Patients: The PiSCES Project,” Journal of Women's Health (Larchmt) 15, no. 2 (2006): 146–154.

McClish D. K. Smith W. R. Dahman B. A. Levenson J. L. Roberts J. D. Penberthy L. T. Aisiku I. P. Roseff S. D. Bovbjerg V. E. , “Pain Site Frequency and Location in Sickle Cell Disease: The PiSCES Project,” Pain 145, nos. 1–2 (2009): 246–251.

Platt O. S. Thorington B. D. Brambilla D. J. Milner P. F. Rosse W. F. Vichinsky E. Kinney T. R. , “Pain in SCD: Rates and Risk Factors,” New England Journal of Medicine 325, no. 1 (1991): 11–16.

Dampier C. Ely E. Brodecki D. O'Neal P. , “Home Management of Pain in Sickle Cell Disease: A Daily Diary Study in Children and Adolescents,” Journal of Pediatric Hematology/Oncology 24, no. 8 (2002): 643–647.

Smith W. R. Bovbjerg V. E. Penberthy L. T. McClish D. K. Levenson J. L. Roberts J. D. Gil K. Roseff S. D. Aisiku I. P. , “Understanding Pain and Improving Management of Sickle Cell Disease: The PiSCES Study,” Journal of the National Medical Association 97, no. 2 (2005): 183–193.

Smith W. R. McClish D. K. Penberthy L. T. Bovbjerg V. E. Dahman B. A. Roberts J. D. Aisiku I. P. Levenson J. L. Roseff S. D. , “Daily Assessment of Pain in Adults with Sickle Cell Disease,” Annals of Internal Medicine 148, no. 2 (2008): 94–101.

Ballas S. K. , “Defining the Phenotypes of Sickle Cell Disease,” Hemoglobin 35, no. 5–6 (2011): 511–519.

Dampier C. Setty B. N. Eggleston B. Brodecki D. O'neal P. Stuart M. , “Vaso-occlusion in Children with Sickle Cell Disease: Clinical Characteristics and Biologic Correlates,” Journal of Pediatric Hematology/Oncology 26, no. 12 (2004): 785–790.

Platt O. S. Brambilla D. J. Rosse W. F. Milner P. F. Castro O. Steinberg M. H. Klug P. P. , “Mortality in Sickle Cell Disease: Life Expectancy and Risk Factors for Early Death,” New England Journal of Medicine 330, no. 23 (1994): 1639–1644.

Smith W. R. , “Pain in Sickle Cell Disease: The Future of Acute Treatment,” Expert Review of Hematology 4, no. 3 (2011): 237–239.

Hebbel R. P. Vercellotti G. Nath K. A. , “A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxsis,” Cardiovascular & Hematological Disorders-Drug Targets 9, no. 4 (2009): 271–292.

Conran N. Franco-Penteado C. F. Costa F. F. , “Newer Aspects of the Pathophysiology of Sickle Cell Disease Vaso-Occlusion,” Hemoglobin 33, no. 1 (2009): 1–16.

Charache S. Terrin M. L. Moore R. D. Dover G. J. McMahon R. P. Barton F. B. Waclawiw M. Eckert S. V. , and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, “Design of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia,” Controlled Clinical Trials 16 (1995): 432–446.

Charache S. Terrin M. L. Moore R. D. , “Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia: Investigators of the Multicenter study of Hydroxyurea in Sickle Cell Anemia,” New England Journal of Medicine 332 (1995): 1317–1322.

Steinberg M. H. Barton F. Castro O. , “Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits up to 9 Years of Treatment,” JAMA 289 (2003): 1645–1651.

Steinberg M. H. McCarthy W. F. Castro O. Ballas S. K. Armstrong F. D. Smith W. Ataga K. Swerdlow P. Kutlar A. DeCastro L. Waclawiw M. A. (Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up, “The Risks and Benefits of Long-Term Use of Hydroxyurea in Sickle Cell Anemia: A 17.5 Year Follow-Up,” American Journal of Hematology 85, no. 6 (2010): 403–408.

Costigan M. Scholz J. Woolf C. J. , “Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage,” Annual Review of Neuroscience 32 (2009):1–32.

Ballas S. K. Gupta K. Adams-Graves P. , “Sickle Cell Pain: A Critical Reappraisal,” Blood 120, no. 18 (2012): 3647–3656.

See Smith , supra note 9.

Kato G. J. Hebbel R. P. Steinberg M. H. Gladwin M. T. , “Vasculopathy in Sickle Cell Disease: Biology, Pathophysiology, Genetics, Translational Medicine, and New Research Directions,” American Journal of Hematology 84, no. 9 (2009): 618–625.

Ballas S. K. Smith E. D. , “Red Blood Cell Changes during the Evolution of the Sickle Cell Painful Crisis,” Blood 79 (1992): 2154–2163.

Brandow A. M. Brousseau D. C. Panepinto J. A. , “Postdischarge Pain, Functional Limitations and Impact on Caregivers of Children with Sickle Cell Disease Treated for Painful Events,” British Journal of Haematology 144, no. 5 (2009): 782–788;.

Ballas S. K. Lusardi M. , “Hospital Readmission for Adult Acute Sickle Cell Painful Episodes: Frequency, Etiology, and Prognostic Significance,” American Journal of Hematology 79 (2005): 17–25.

Smith W. R. Scherer M. , “Sickle-Cell Pain: Advances in Epidemiology and Etiology,” Hematology: American Society of Hematology Education Program 2010, no. 1 (2010): 409–415.

Wilkie D. J. Molokie R. Boyd-Seal D. Suarez M. L. Kim Y. O. Zong S. Wittert H. Zhao Z. Saunthararajah Y. Wang Z. J. , “Patient-Reported Outcomes: Descriptors of Nociceptive and Neuropathic Pain and Barriers to Effective Pain Management in Adult Outpatients with Sickle Cell Disease,” Journal of the National Medical Association 102, no. 1 (2010): 18–27.

Flor H. , “Maladaptive Plasticity, Memory for Pain and Phantom Limb Pain: Review and Suggestions for New Therapies,” Expert Review in Neurotherapeutics 8, no. 5 (2008): 809–818.

Stisi S. Cazzola M. Buskila D. Spath M. Giamberardino M. A. Sarzi-Puttini P. Arioli G. Alciati A. Leardini G. Gorla R. Marsico A. Ceccherelli F. Bazzichi L. Carignola R. Gracely R. H. Salaffi F. Marinangeli F. Torta R. Di Franco M. Biasi G. Cassisi G. Casale R. Altomonte L. Atzeni F. (Italian Fibromyalgia Network), “Etiopathogenetic Mechanisms of Fibromyalgia Syndrome,” Reumatismo 60, Supp. 1 (2008): 25–35;.

Harris R. E. Clauw D. J. Scott D. J. McLean S. A. Gracely R. H. Zubieta J. K. , “Decreased Central Mu-Opioid Receptor Availability in Fibromyalgia,” Journal of Neuroscience 27, no. 37 (2007): 10000–10006.

Lembo T. Naliboff B. D. Matin K. Munakata J. Parker R. A. Gracely R. H. Mayer E. A. , “Irritable Bowel Syndrome Patients Show Altered Sensitivity to Exogenous Opioids,” Pain 87, no. 2 (2000): 137–147.

Ballas S. K. Bauserman R. L. McCarthy W. F. Castro O. L. Smith W. R. Waclawiw M. A. (Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia), “Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization during Hospitalization, Outpatient Acute Care Contacts, and at Home,” Journal of Pain and Symptom Management 40, no. 6 (2010): 870–882.

Ballas S. K. Bauserman R. L. McCarthy W. F. Castro O. L. Smith W. R. Waclawiw M. A. (Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia), “Utilization of Analgesics in the Multicenter study of Hydroxyurea in Sickle Cell Anemia: Effect of Sex, Age, and Geographical Location,” American Journal of Hematology 85, no. 8 (2010): 613–616.

Smith W. R. Ballas S. K. McCarthy W. F. Bauserman R. L. Swerdlow P. S. Steinberg M. H. Waclawiw M. A. (Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia), “The Association between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients,” Pain Medicine 12, no. 5 (2011): 697–705.

See Smith , supra note 9.

See Platt , supra note 7.

Meehan W. J. Adelman S. A. Rehman Z. Khoromi S. , “Opioid Abuse”.

Weaver M. F. Schnoll S. H. , “Opioid treatment of Chronic Pain in Patients with Addiction,” Journal of Pain and Palliative Care Pharmacotherapy 16 (2002): 5–26.

Shapiro B. S. Benjamin L. J. Payne R. Heidrich G. , “Sickle Cell-Related Pain: Perceptions of Medical Practitioners,” Journal of Pain Symptom Manage 14, no. 3 (1997): 168–174.

Aisiku I. P. Reid R. D. Smith W. R. , “Case Studies in Pain Management: Episodic Pain in Sickle Cell Disease,” Emergency Medicine 41, no. 2 (2009): 8.

Smith W. R. Jordan L. B. Hassell K. L. , “Frequently Asked Questions by Hospitalists Managing Pain in Adults with Sickle Cell Disease,” Journal of Hospital Medicine 6, no. 5 (2011): 297–303.

Chen I. Kurz J. Pasanen M. Faselis C. Panda M. Staton L. J. O'Rorke J. Menon M. Genao I. Wood J. Mechaber A. J. Rosenberg E. Carey T. Calleson D. Cykert S. , “Racial Differences in Opioid Use for Chronic Nonmalignant Pain,” Journal of General Internal Medicine 20, no. 7 (2005): 593–598.

SAMHSA, Overview of Findings from the 2003 National Survey on Drug Use and Health, Office of Applied Studies, NSDUH Series H-24, DHHS Publication No. SMA 04–3963 (2004).

Beyer J. E. , “Judging the Effectiveness of Analgesia for Children and Adolescents during Vaso-Occlusive Events of Sickle Cell Disease,” Journal of Pain Symptom Management 19 (2000): 63–72.

Wilkinson G. R. , “Drug Metabolism and Variability among Patients in Drug Response,” New England Journal of Medicine 352, no. 21 (2005): 2211–2221;.

Shord S. S. Cavallari L. H. Gao W. Jeong H. Y. Deyo K. Patel S. R. Camp J. R. Labott S. M. Molokie R. E. , “The Pharmacokinetics of Codeine and Its Metabolites in Blacks with Sickle Cell Disease,” European Journal of Clinical Pharmacology 65, no. 7 (2009): 651–658;.

Darbari D. S. Neely M. van den Anker J. Rana S. , “Increased Clearance of Morphine in Sickle Cell Disease: Implications for Pain Management,” Journal of Pain 12, no. 5 (2011): 531–538.

Aisiku I. P. Smith W. R. McClish D. K. Levenson J. L. Penberthy L. T. Roseff S. D. Bovbjerg V. E. Roberts J. D. , “Comparisons of High Versus Low Emergency Department Utilizers in Sickle Cell Disease,” Annals of Emergency Medicine 53, no. 5 (2009): 587–593.

Klaassen C. D. , Casarett & Doull's Toxicology: The Basic Science of Poisons, 6th ed. (New York: McGraw-Hill Professional, 2001): At 17.

Roshanpour M. Ghasemi M. Riazi K. Rafiei-Tabatabaei N. Ghahremani M. H. Dehpour A. R. , “Tolerance to the Anticonvulsant Effect of Morphine in Mice: Blockage by Ultra-Low Dose Naltrexone,” Epilepsy Research 83, no. 2–3 (2009): 261–264.

Koch T. Höllt V. , “Role of Receptor Internalization in Opioid Tolerance and Dependence,” Pharmacology & Therapeutics 117, no. 2 (2008): 199–206.

South S. M. Smith M. T. , “Analgesic Tolerance to Opioids: International Association for the Study of Pain,” Pain: Clinical Updates 9, no. 5 (2001): 1–4.

Miotto K. , “Diagnosing Addictive Disease in Chronic Pain Patients,” Psychosomatics 37 (1996): 223–235.

Bobo L. Miller S. T. Smith W. R. Elam J. T. Rosmarin P. C. Lancaster D. J. , “Health Perceptions and Medical Care Opinions of Inner-City Adults with Sickle Cell Disease and Asthma Compared with Their Siblings,” Southern Medical Journal 82 (1989): 9–12;.

Coulton C. Frost A. K. , “Use of Social and Health Services by the Elderly,” Journal of Health and Social Behavior 23 (1982): 330.

Murray N. , “Painful Crises in Sickle Cell Disease -Patients' Perspectives,” BMJ 297, no. 6646 (1988): 452–454.

Brookoff D. Polomano R. , “Treating Sickle Cell Pain Like Cancer Pain,” Annals of Internal Medicine 166, no. 5 (1992): 364–368.

The American Academy of Pain Medicine and the American Pain Society, “The Use of Opioids for the Treatment of Chronic Pain: A Consensus Statement from the American Academy of Pain Medicine and the American Pain Society,” Clinical Journal of Pain 13 (1997): 6–8.

Caudill-Slosberg M. A. Schwartz L. M. Woloshin S. , “Office Visits and Analgesic Prescriptions for Musculoskeletal Pain in US: 1980 vs 2000,” Pain 109 (2004): 514–519;.

Olsen Y. Daumit G. L. Ford D. E. , “Opioid Prescriptions by US Primary Care Physicians from 1992 to 2001,” Journal of Pain 7 (2006): 225–235.

Bohnert A. S. Valenstein M. Bair M. J. Ganoczy D. McCarthy J. F. Ilgen M. A. Blow F. C. , “Association between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths,” JAMA 305, no. 13 (2011): 1315–1321.

Colliver J. D. Kroutil L. A. Dai L. Gfroerer J. C. , Misuse of Prescription Drugs: Data from the 2002, 2003, 2nd 2004 National Surveys on Drug Use and Health, DHHS Publication no. SMA 06–4192, Analytic Series A-28 (Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2006).

Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1995–2002, DAWN Series D-24, DHHS Publication no. SMA 03–3780 (Rockville, MD: DHHS, 2003).

Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Results from the 2005 National Survey on Drug Use and Health: National Findings, NSDUH Series H-30, DHHS Publication No. SMA 06–4194 (Rockville, MD: DHHS, 2006a).

Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Treatment Episode Data Set (TEDS): Highlights - 2005: National Admissions to Substance Abuse Treatment Services, DHHS DASIS Series: S-36, DHHS Publication No. SMA 07–4229 (Rockville, MD: DHHS, 2006b).

Substance Abuse and Mental Health Services Administration, Office of Applied Studies, The NSDUH Report: Patterns and Trends in Nonmedical Prescription Pain Reliever Use: 2002 to 2005, available at <http://www.oas.samhsa.gov/2k7/pain/pain.htm>(last visited March 27, 2014).

Drug Enforcement Administration, “A Joint Statement from 21 Health Organizations and the Drug Enforcement Administration: Promoting Pain Relief and Preventing Abuse of Pain Medications: A Critical Balancing Act,” Journal of Pain and Symptom Management 24, no. 2 (2002): 147;.

Chou R. Fanciullo G. J. Fine P. G. Adler J. A. Ballantyne J. C. Davies P. Donovan M. I. Fishbain D. A. Foley K. M. Fudin J. Gilson A. M. Kelter A. Mauskop A. O'Connor P. G. Passik S. D. Pasternak G. W. Portenoy R. K. Rich B. A. Roberts R. G. Todd K. H. Miaskowski C. (American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel), “Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain,” Journal of Pain 10, no. 2 (2009): 113–130.

Manchikanti L. Abdi S. Atluri S. Balog C. C. Benyamin R. M. Boswell M. V. Brown K. R. Bruel B. M. Bryce D. A. Burks P. A. Burton A. W. Calodney A. K. Caraway D. L. Cash K. A. Christo P. J. Damron K. S. Datta S. Deer T. R. Diwan S. Eriator I. Falco F. J. Fellows B. Geffert S. Gharibo C. G. Glaser S. E. Grider J. S. Hameed H. Hameed M. Hansen H. Harned M. E. Hayek S. M. Helm S. Hirsch J. A. Janata J. W. Kaye A. D. Kaye A. M. Kloth D. S. Koyyalagunta D. Lee M. Malla Y. Manchikanti K. N. McManus C. D. Pampati V. Parr A. T. Pasupuleti R. Patel V. B. Sehgal N. Silverman S. M. Singh V. Smith H. S. Snook L. T. Solanki D. R. Tracy D. H. Vallejo R. Wargo B. W. (American Society of Interventional Pain Physicians), “American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain: Part I – Evidence Assessment,” Pain Physician 15, no. 3, Supp. (2012): S1–S65.

Manchikanti L. Abdi S. Atluri S. Balog C. C. Benyamin R. M. Boswell M. V. Brown K. R. Bruel B. M. Bryce D. A. Burks P. A. Burton A. W. Calodney A. K. Caraway D. L. Cash K. A. Christo P. J. Damron K. S. Datta S. Deer T. R. Diwan S. Eriator I. Falco F. J. Fellows B. Geffert S. Gharibo C. G. Glaser S. E. Grider J. S. Hameed H. Hameed M. Hansen H. Harned M. E. Hayek S. M. Helm S. Hirsch J. A. Janata J. W. Kaye A. D. Kaye A. M. Kloth D. S. Koyyalagunta D. Lee M. Malla Y. Manchikanti K. N. McManus C. D. Pampati V. Parr A. T. Pasupuleti R. Patel V. B. Sehgal N. Silverman S. M. Singh V. Smith H. S. Snook L. T. Solanki D. R. Tracy D. H. Vallejo R. Wargo B. W. (American Society of Interventional Pain Physicians), “American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain: Part 2 – Guidance,” Pain Physician 15, no. 3, Supp. (2012): S67–S116.

Swegle J. M. Logemann C. , “Management of Common Opioid-Induced Adverse Effects,” American Family Physician 74, no. 8 (2006): 1347–1354.

Obama Administration Releases Action Plan to Address National Prescription Drug Abuse Epidemic: New Strategy Strikes Balance between Cracking down on Drug Diversion and Protecting Delivery of Effective Pain Management, DEA News Release, April 19, 2011, ONDCP Public Affairs Number: 202-395–6618, available at <http://www.justice.gov/dea/pubs/pressrel/pr041911.html>(last visited March 27, 2014).

Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed. (Glenview, IL: American Pain Society, 2003).

Ives T. J. Chelminski P. R. Hammett-Stabler C. A. Malone R. M. Perhac J. S. Potisek N. M. Shilliday B. B. DeWalt D. A. Pignone M. P. , “Predictors of Opioid Misuse in Patients with Chronic Pain: A Prospective Cohort Study,” BMC Health Services Research 6 (2006): 46.

Levenson J. L. McClish D. K. Dahman B. A. Penberthy L. T. Bovbjerg V. E. Aisiku I. P. Roseff S. D. Smith W. R. , “Alcohol Abuse in Sickle Cell Disease: The Pisces Project,” American Journal of Addiction 16, no. 5 (2007): 383–388.

Campos-Outcalt D. , “Should You Screen – or Not? The Latest Recommendations,” Journal of Family Practice 57, no. 7 (2008): 469–472.

Aisiku I. P. Penberthy L. T. Smith W. R. Bovbjerg V. E. McClish D. K. Levenson J. L. Roberts J. D. Roseff S. D. , “Patient Satisfaction in Specialized Versus Nonspecialized Adult Sickle Cell Care Centers: The PiSCES Study,” Journal of the National Medical Association 99, no. 8 (2007): 886–890.